Insights
Stay ahead on trends, new solutions, and cutting-edge technologies
Latest Insights
Life Sciences, AI, Clinical, Data
GenAI in Pharma: Molecule Discovery Automation with NNIT
Read more
Insights that drive innovation in highly-regulated industries
Get your inspiration here and expand your knowledge across key domains. From cybersecurity and compliance to digital transformation in life sciences and the public sector, our insights help you explore targeted areas of expertise.
Life Sciences, Smart supply-chain
NDC-12: Time Waits for No One
Private, Public, AI, Software Engineering
Agentic Engineering Can Change How the Public Sector Develops Digital Solutions
Life Sciences, Quality, Veeva Solutions
From Retrospective Control to Predictive Assurance: How AI Is Changing What It Means to Be in Control
Public, AI
AI in the public sector: From pilots to responsible operations
Life Sciences, Compliance
The road to better medicine is paved with data
Life Sciences, Smart supply-chain
Your life sciences data flow must match the movement of your physical products
Life Sciences, Digital Manufacturing
Are data blind spots hurting your pharma manufacturing?
Life Sciences, Compliance
Compliance by design: How validated platforms turn digital transformation into lasting control
Private, Public, SAP Solutions
In a changing world with geopolitical tensions, the SAP of the future requires a new and balanced approach: On-prem, cloud, or hybrid?
Life Sciences, Digital Manufacturing
Ignition Premier Integrator
Life Sciences, Digital Manufacturing
Beyond configuration: the centrality of the process in MES implementation
Life Sciences, AI, Data
From Hype to Reality: Architectural, Strategic, and Data Lessons for AI in Pharma
Life Sciences, Private, Public, AI
Agentic AI vs. AI Agents: Why This Distinction Matters Across Regulated Industries
Life Sciences, Clinical, Data, Digital Manufacturing, Drug Safety, Regulatory Affairs, Smart supply-chain
How to build a universal translator for pharma data with FHIR
Life Sciences, AI, Clinical, Data, Drug Safety, Regulatory Affairs